Affinivax Announces Collaboration with PATH to Advance the Company’s Lead Vaccine Candidate for Pneumococcal Disease
X-Chem and Navitor Pharmaceuticals Enter into License Agreement on Novel Small Molecules Targeting mTORC1 Activation
Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics
Unum Therapeutics Announces $65 Million Series B Financing Round
XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders
New Commitments in Support of the President’s Nation of Makers Initiative
Aquinnah Pharmaceuticals Receives $0.5M In Grants From the ALS Association
NantKwest Announces Launch of Initial Public Offering
Unum Therapeutics Names Geoffrey Hodge as Senior Vice President, Operations
NantKwest Announces Prostate Cancer Foundation $1 Million Challenge Award to Study a Novel Natural Killer Cell Therapy in Prostate Cancer
